AI News

London's Canary Wharf is transforming into a European life sciences hub—what new sparks will China-UK investment cooperation ignite?

YicaiUpdated Nov 16 21:09

AI summary

London Life Sciences Week (LSW2026) has opened, with more than 80 events attracting over 1,300 life sciences investors, including a large Chinese delegation. Zhao Bingbing, Chief Representative for Greater China at London & Partners, said that Canary Wharf will build a large number of laboratories, that the UK Medicines and Healthcare products Regulatory Agency has already moved in, and that it will transform into an emerging European life sciences hub in the future. Over the past six years, the agency has supported a total of 119 Chinese companies in developing their businesses in London.

Body · AI translation

In the field of biopharmaceutical R&D, the birth of a new drug is often not the "solo effort" of a scientist in a laboratory, but requires frequent "collisions" among academia, industry, and investors.

On the 16th local time, London Life Sciences Week (LSW2026), Europe's largest annual life sciences industry event, will officially open. As one of the organizers of the event, Zhao Bingbing, Chief Representative for Greater China of London & Partners (L&P), told Yicai Global that this year's London Life Sciences Week will host more than 80 events, with participants from around the world and more than 1,300 life sciences investors gathering in London. Among them will be a large Chinese delegation in the life sciences field.

"In fact, compared with London Tech Week, which has been held for 15 years, London Life Sciences Week is younger, and this year is only the third edition," Zhao Bingbing said. "It is precisely because during London Tech Week we saw the particularity of the life sciences industry circle and investment ecosystem that we decided to hold a separate week-long series of events in London each year focused on the life sciences field."

Canary Wharf in London is transforming into a life sciences hub

According to Zhao Bingbing, at the previously held Bio Shanghai in Zhangjiang, Shanghai, London Life Sciences Week and Bio Shanghai formally reached a strategic cooperation aimed at connecting the industrial platforms of the two places and promoting two-way industrial matchmaking. After the strategic cooperation was implemented, eight life sciences companies from the London International Accelerator have visited Shanghai, Zhangjiang, and Suzhou for industrial exchanges.

Zhao Bingbing said that at this year's London Life Sciences Week, in addition to the official agenda, the Chinese delegation will also participate in a number of supporting activities, including a visit to London's Canary Wharf. "When people mention Canary Wharf, everyone will certainly define it as a financial center, but according to the latest urban planning of the London municipal government, Canary Wharf will build a large number of laboratories of different sizes. At present, the UK Medicines and Healthcare products Regulatory Agency has moved here, and R&D teams from many UK universities have also gathered here, forming an emerging industrial cluster. In the future, Canary Wharf will transform into an emerging life sciences center in Europe."

London's vigorous development of the life sciences field has actually long had traces to follow. In the middle of last year, the UK government released the "Modern Industrial Strategy," anchored to development over the next 10 years and focusing on eight high-growth sectors, including advanced manufacturing, clean energy, digital technology, financial services, life sciences, creative industries, defense, and professional services, aiming to promote investment, create high-skilled jobs, and enhance the UK's competitiveness in the global business environment. Earlier last year, the London municipal government released the "London Growth Plan," hoping to restore London's average annual productivity growth rate to 2% within the next decade.

She said that in the life sciences field, Chinese companies have advantages in fast R&D implementation, controllable costs, and strong scaling capabilities; the UK has cutting-edge R&D ideas in the pharmaceutical field. "The two sides can link cooperation entities such as CROs (contract research organizations), CDMOs (contract development and manufacturing organizations), and clinical institutions to shorten the entire process cycle from drug R&D, compliance approval, and licensing to global sales. The results of China-UK cooperation can benefit the world," she said.

In AI and frontier technologies, Zhao Bingbing said that London is currently focusing on frontier tracks such as artificial intelligence and quantum computing. "(China and the UK) can conduct exchanges around common issues such as data protection and AI governance, jointly seize technological opportunities and respond to potential risks."

Changes in Chinese companies' investment

In recent years, more and more Chinese companies have established a presence in London and the UK market, and Zhao Bingbing, who has worked at London & Partners for 15 years, feels this deeply. In her view, the current model of Chinese companies landing in London has changed significantly compared with the past three to five years.

Zhao Bingbing gave examples: in the early days, Chinese companies going to the UK were mostly trading companies, central state-owned enterprises, and other large enterprises, concentrated in traditional industries; later, companies related to China's "new three" (new energy vehicles, lithium batteries, and photovoltaic products) became the main force investing and developing in the UK market, with the driving force for going global coming more from the export of domestic production capacity. At the current stage, Zhao Bingbing said she has seen that Chinese companies going global are no longer limited to exporting production capacity and products, but are more about exporting China's locally leading innovative technologies and innovative business models, which is particularly notable in tracks such as original innovative drugs and AI applications.

Data from London & Partners show that over the past six years, the organization has supported 119 Chinese companies in developing their businesses in London, covering industries such as creative technology, enterprise technology, green innovation, fintech and cybersecurity, and life sciences.

At the previously concluded ninth China International Import Expo, London & Partners joined forces with the Greater Manchester Business Growth Hub to organize six companies from the Greater Manchester region of the UK to explore the expo. The companies covered multiple tracks including industrial digital twins, AI visual inspection, food manufacturing, and specialty alcoholic beverages.

"For many UK companies, the Chinese market is no longer an 'optional question' but a 'must-answer question,'" Zhao Bingbing told Yicai Global. "Large Chinese exhibitions such as the CIIE can help foreign companies that are new to the scene, especially small and medium-sized foreign-funded enterprises, accumulate networking resources and provide market insights, gradually build partnerships, explore development paths suitable for themselves, and lay the foundation for their subsequent long-term, sustainable growth in the Chinese market."

Source

Yicai